-
公开(公告)号：KR1020110036317A
公开(公告)日：2011-04-07
申请号：KR1020090093911
申请日：2009-10-01
Applicant: 재단법인 제주테크노파크
IPC: A61K36/37 , A61P29/00 , A23L1/30 , A61K36/232
Abstract: PURPOSE: An anti-inflammatory composition is provided to be applied to a pharmaceutical composition or food composition. CONSTITUTION: An anti-inflammatory composition contains complex plant extract as an active ingredient. The plant extract is isolated using methanol, ethanol, acetone, ethyl acetate, saturated normal butanol, chloroform, methylene chloride, water, or mixture solvent thereof. The composition is a pharmaceutical composition or food composition. The composition is formulated for oral administration or parenteral administration by adding a carrier, excipient, and additive.
Abstract translation: 目的：提供用于药物组合物或食物组合物的抗炎组合物。 构成：抗炎组合物含有复合植物提取物作为活性成分。 使用甲醇，乙醇，丙酮，乙酸乙酯，饱和正丁醇，氯仿，二氯甲烷，水或其混合溶剂分离植物提取物。 组合物是药物组合物或食物组合物。 通过添加载体，赋形剂和添加剂将组合物配制成用于口服给药或肠胃外给药。
-
公开(公告)号：KR101326158B1
公开(公告)日：2013-11-06
申请号：KR1020100128143
申请日：2010-12-15
Applicant: 재단법인 경기과학기술진흥원 , 재단법인 제주테크노파크
Abstract: 본 발명은 항히스타민제 조성물을 개시한다. 구체적으로 본 발명은 비만세포의 탈과립을 억제하는 활성을 가진, 갯무 잎 추출물 등의 식물 유래 추출물, 부채말 전초 추출물 등 해조류 유래 추출물 등을 이용한 항히스타민제 조성물을 개시한다.
-
Patent Agency Ranking
公开(公告)号：KR101291774B1
公开(公告)日：2013-08-08
申请号：KR1020110028273
申请日：2011-03-29
Applicant: 주식회사 휴스콘 , 재단법인 제주테크노파크
Abstract: 본 발명은 큰비쑥의 재배용 토양 조성물 및 이를 이용한 큰비쑥의 인공 재배 방법을 개시한다.
본 발명의 큰비쑥의 재배용 토양 조성물은 모래, 펄라이트(Perlite) 및/또는 피트모스를 포함하여 구성되며, 이를 큰비쑥의 인공 재배 방법은 상기 조성물에 큰비쑥 종자를 파종하고 물을 관수하는 단계 및 성장을 유도하는 단계를 포함하여 구성된다.-
公开(公告)号：KR1020120100859A
公开(公告)日：2012-09-12
申请号：KR1020120082039
申请日：2012-07-26
Applicant: 재단법인 제주테크노파크
CPC classification number: A61K36/60 , A23L33/105 , A23V2002/00 , A23V2200/324
Abstract: PURPOSE: An anti-inflammatory composition using Ficus erecta leaf extract is provided to suppress IL-1beta generation and iNOS and COX-2 expression. CONSTITUTION: An anti-inflammatory composition contains Ficus erecta leaf extract as an active ingredient. The extract is selected from: extract prepared with alcohol of 1-5 carbon atoms, acetone, hexane, ethyl acetate, dichloromethane, water or a mixture thereof; extract of a fraction solvent layer prepared by fractioning solid extract with water and hexane, water and dichloromethane, or water and ethyl acetate; and extract prepared by suspending the solid extract in the water and fractioning with hexane, dichloromethane, and ethyl acetate in order. The composition is a pharmaceutical composition and food composition.
Abstract translation: 目的：提供使用Ficus erecta叶提取物的抗炎组合物，以抑制IL-1beta的产生和iNOS和COX-2的表达。 构成：抗炎组合物含有榕叶提取物作为活性成分。 提取物选自：用1-5个碳原子的醇制备的提取物，丙酮，己烷，乙酸乙酯，二氯甲烷，水或其混合物; 通过用水和己烷，水和二氯甲烷或水和乙酸乙酯分离固体提取物制备的级分溶剂层的提取物; 和通过将固体提取物悬浮在水中制备的提取物，并依次用己烷，二氯甲烷和乙酸乙酯分馏。 组合物是药物组合物和食物组合物。
-
公开(公告)号：KR1020110036330A
公开(公告)日：2011-04-07
申请号：KR1020090093932
申请日：2009-10-01
Applicant: 재단법인 제주테크노파크 , 주식회사 휴스콘
IPC: A61K36/282 , A61P29/00 , A61P31/00
Abstract: PURPOSE: An Artemisia fukudo leaf essential oil extract is provided to ensure anti-inflammatory activity and anti-microbial activity. CONSTITUTION: An Artemisia fukudo leaf essential oil extract is obtained by distillation extract of Artemisia fukudo leaf using water vapor. A pharmaceutical composition contains the Artemisia fukudo leaf essential oil extract, carrier, and excipient. The pharmaceutical composition is used in the form of an oral formulation(tablet, suspension, granule, emulsion, capsule, and syrup); a parenteral formulation(sterilized injection aqueous or oily suspension);and a topical formulation(solution, cream, ointment, gel, lotion, and patch).
Abstract translation: 目的：提供艾蒿叶精油提取物，以确保抗炎活性和抗微生物活性。 构成：通过使用水蒸气的蒿叶蒿蒸馏提取物获得蒿叶精油提取物。 药物组合物含有蒿叶精油提取物，载体和赋形剂。 药物组合物以口服制剂（片剂，悬浮液，颗粒剂，乳剂，胶囊剂和糖浆剂）的形式使用; 肠胃外制剂（无菌注射含水或油性悬浮液）;和局部制剂（溶液，霜剂，软膏，凝胶，洗剂和贴剂）。
-
公开(公告)号：KR1020100122376A
公开(公告)日：2010-11-22
申请号：KR1020090041384
申请日：2009-05-12
Applicant: 재단법인 제주테크노파크
IPC: A61K36/185 , A61K8/97 , A61P11/06 , A61Q19/00
Abstract: PURPOSE: A composition containing kiwi leaf extract for anti-inflammation is provided to apply to atopic dermatitis. CONSTITUTION: A composition for anti-inflammation contains kiwi leaf extract as an active ingredient. The extract is obtained using water, distilled water, ethanol or mixture solvent thereof. The composition is a pharmaceutical composition. The composition is also a cosmetic composition for relieving atopic dermatitis. A composition for relieving atopic dermatitis contains kiwi pulp extract as an active ingredient.
Abstract translation: 目的：提供含有抗炎的猕猴桃提取物的组合物适用于特应性皮炎。 构成：抗炎组合物含有猕猴桃提取物作为活性成分。 萃取液用水，蒸馏水，乙醇或其混合溶剂得到。 组合物是药物组合物。 该组合物也是用于缓解特应性皮炎的化妆品组合物。 用于缓解特应性皮炎的组合物含有猕猴桃提取物作为活性成分。
-
公开(公告)号：KR1020090118154A
公开(公告)日：2009-11-18
申请号：KR1020080043774
申请日：2008-05-13
Applicant: 재단법인 제주테크노파크
IPC: A61K36/185 , A61P17/18 , A61P35/00
Abstract: PURPOSE: A composition containing Quercus acuta Thunb extract is provided to ensure the effect of DNA damage suppression and cancer cell proliferation suppression. CONSTITUTION: A method for producing fraction of Quercus acuta Thunb extract comprises: a step of preparing stems with leaves of Quercus acuta Thunb then pulverizing; a step of extracting the pulverized Quercus acuta Thunb powder with ethanol; a step of decompress-concentrating then suspending with distilled water; and a step of extracting with hexane, dichloromethane, ethylacetate, butanol, and water. A composition for antioxidation contains fraction of Quercus acuta Thunb extract.
Abstract translation: 目的：提供含有栎属藜提取物的组合物，以确保DNA损伤抑制和癌细胞增殖抑制的作用。 构成：生产栎属栎提取物的方法，包括：用槲皮栎树叶制备茎的步骤，然后粉碎; 用乙醇提取粉碎的栎树栎粉末的步骤; 减压浓缩步骤，然后用蒸馏水悬浮; 和用己烷，二氯甲烷，乙酸乙酯，丁醇和水萃取的步骤。 用于抗氧化的组合物含有栎属栎提取物的分数。
-
-
-
-
-
-
Search Results
27
records
(took 0.026 seconds)
